MedPath

Exploring the effect of ketamine at the dose of flax drunkenness on supporting laryngoscopy surgery

Phase 1
Conditions
diseases of larynx
Registration Number
ChiCTR2400088728
Lead Sponsor
Shanghai Changhai Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Age: 18~64 years old<br>2. BMI: 18-30kg/m2<br>3. ASA Level I or II<br>4. Patients undergoing supportive laryngoscopy surgery under elective general anesthesia<br>5. The patient voluntarily participates and signs an informed consent form
Exclusion Criteria
  1. Allergic to ketamine<br>2. Patients who are pregnant or breastfeeding<br>3. History of severe hypertension and heart disease<br>4. History of chronic obstructive diseases and asthma<br>5. Severe liver and kidney dysfunction<br>6. History of psychiatric disorders<br>7. Hyperthyroidism patients<br>8. Patients with increased intracranial pressure and intraocular pressure

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Whether it can reduce the incidence of cardiovascular adverse events ;
Secondary Outcome Measures
NameTimeMethod
Whether it can improve the quality of awakening and alleviate postoperative pain for patients;
© Copyright 2025. All Rights Reserved by MedPath